• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在津巴布韦哈拉雷的比阿特丽斯路医院和威尔金斯传染病医院机会性感染诊所,对接受司他夫定(Stalanev,司他夫定、拉米夫定和奈韦拉平)治疗的成人血浆乳酸水平影响的调查。

Investigation of the effect of Stalanev (Stavudine, Lamivudine and Nevirapine) treatment on plasma lactate levels in adults attending Beatrice Road and Wilkins Infectious Diseases Hospital Opportunistic Infections Clinics in Harare, Zimbabwe.

作者信息

Malunga G, Mujaji W B, Musarurwa C, Nyamayaro T

机构信息

Wilkins Infectious Diseases Hospital Laboratory, University of Zimbabwe College of Health Sciences, Harare, Zimbabwe.

出版信息

Cent Afr J Med. 2012 May-Aug;58(5-6):22-5.

PMID:26255331
Abstract

MAIN OBJECTIVE

To evaluate the effect of Stalanev (Stavudine, Lamivudine and Nevirapine) treatment on plasma lactate levels in adults attending Beatrice Road Infectious Diseases Hospital and Wilkins Infectious Diseases Hospital Opportunistic Infections Clinics in Harare.

DESIGN

Prospective cohort study carried out between January and May 2011.

SETTING

Beatrice Road and Wilkins Infectious Diseases Hospital Opportunistic Infections Clinics in Harare, Zimbabwe.

PARTICIPANTS

A convenience sample of 180 ART naive HIV infected adults aged 20-68 years who were about to be initiated on STALANEV were recruited.

RESULTS

The mean plasma lactate at baseline was 1.57 mmol/L (SD 0.43). After two months on STALANEV, 25 participants (13.9%) had hyperlactatemia and the mean plasma lactate level was 1.99 mmol/L (SD 0.49). At four months follow up, 98 participants (54%) had hyperlactatemia and the mean plasma lactate level was 2.65 mmol/l (SD 0.55). Mean plasma lactate levels increased significantly from baseline to 2 months follow up and from 2 months follow up to 4 months follow up (p < 0.001). None of the participants developed lactic acidosis (plasma lactate > 3.5) after two months of follow up but 14 (7.8%) developed mild lactic acidosis and three (1.7%) had moderate lactic acidosis after four months on STALANEV.

CONCLUSIONS

Our findings are in agreement with those of other studies that reported that treatment with STALANEV leads to hyperlactatemia thereby posing a risk for the development of lactic acidosis in patients. In the absence of alternative regimens, we recommend routine monitoring of plasma lactate levels on all patients on STALANEV in Zimbabwe.

摘要

主要目的

评估司他宁(司他夫定、拉米夫定和奈韦拉平)治疗对哈拉雷比阿特丽斯路传染病医院和威尔金斯传染病医院机会性感染门诊就诊的成年患者血浆乳酸水平的影响。

设计

2011年1月至5月进行的前瞻性队列研究。

地点

津巴布韦哈拉雷的比阿特丽斯路和威尔金斯传染病医院机会性感染门诊。

参与者

招募了180名年龄在20 - 68岁、即将开始接受司他宁治疗的初治HIV感染成年患者,作为方便样本。

结果

基线时血浆乳酸平均水平为1.57 mmol/L(标准差0.43)。接受司他宁治疗两个月后,25名参与者(13.9%)出现高乳酸血症,血浆乳酸平均水平为1.99 mmol/L(标准差0.49)。在四个月的随访中,98名参与者(54%)出现高乳酸血症,血浆乳酸平均水平为2.

相似文献

1
Investigation of the effect of Stalanev (Stavudine, Lamivudine and Nevirapine) treatment on plasma lactate levels in adults attending Beatrice Road and Wilkins Infectious Diseases Hospital Opportunistic Infections Clinics in Harare, Zimbabwe.在津巴布韦哈拉雷的比阿特丽斯路医院和威尔金斯传染病医院机会性感染诊所,对接受司他夫定(Stalanev,司他夫定、拉米夫定和奈韦拉平)治疗的成人血浆乳酸水平影响的调查。
Cent Afr J Med. 2012 May-Aug;58(5-6):22-5.
2
Symptomatic hyperlactatemia associated with nucleoside analogue reverse-transcriptase inhibitor use in HIV-infected patients: a report of 24 cases in a resource-limited setting (Uganda).在资源有限环境(乌干达)中,与核苷类似物逆转录酶抑制剂用于HIV感染患者相关的症状性高乳酸血症:24例报告
Clin Infect Dis. 2007 Aug 15;45(4):514-7. doi: 10.1086/520023. Epub 2007 Jul 5.
3
Risk factors for and outcome of hyperlactatemia in HIV-infected persons: is there a need for routine lactate monitoring?HIV感染者高乳酸血症的危险因素及转归:是否需要常规监测乳酸水平?
Clin Infect Dis. 2005 Sep 1;41(5):721-8. doi: 10.1086/432471. Epub 2005 Jul 29.
4
Safety and efficacy of switching to alternative nucleoside analogues following symptomatic hyperlactatemia and lactic acidosis.出现症状性高乳酸血症和乳酸性酸中毒后换用其他核苷类似物的安全性和有效性。
AIDS. 2003 Nov 21;17(17):2495-9. doi: 10.1097/00002030-200311210-00012.
5
Lactic acidosis associated with nucleoside analog therapy in an HIV-positive patient.一名HIV阳性患者中与核苷类似物治疗相关的乳酸性酸中毒。
AIDS Patient Care STDS. 2000 Jul;14(7):339-42. doi: 10.1089/108729100413194.
6
Stavudine- and nevirapine-related drug toxicity while on generic fixed-dose antiretroviral treatment: incidence, timing and risk factors in a three-year cohort in Kigali, Rwanda.在卢旺达产通用固定剂量抗逆转录病毒治疗方案中,司他夫定和奈韦拉平相关药物毒性:基加利三年队列研究中的发生率、时间和危险因素。
Trans R Soc Trop Med Hyg. 2010 Feb;104(2):148-53. doi: 10.1016/j.trstmh.2009.07.009. Epub 2009 Sep 3.
7
Effectiveness of fixed-dose combination stavudine, lamivudine and nevirapine (GPO-VIR) for treatment of naïve HIV patients in Thailand: a 3-year follow-up.固定剂量组合司他夫定、拉米夫定和奈韦拉平(GPO-VIR)治疗泰国初治HIV患者的疗效:3年随访
Southeast Asian J Trop Med Public Health. 2011 Nov;42(6):1414-22.
8
Fanconi syndrome and lactic acidosis associated with stavudine and lamivudine therapy.与司他夫定和拉米夫定治疗相关的范科尼综合征和乳酸性酸中毒。
AIDS. 2008 Jul 11;22(11):1374-6. doi: 10.1097/QAD.0b013e328303be50.
9
The efficacy and adverse effects of GPO-VIR (stavudine+lamivudine+nevirapine) in treatment-naïve adult HIV patients.GPO-VIR(司他夫定+拉米夫定+奈韦拉平)在初治成年HIV患者中的疗效及不良反应。
Southeast Asian J Trop Med Public Health. 2005 Mar;36(2):362-9.
10
Metabolic benefits of switching to tenofovir/lamivudine after long-term use of stavudine/lamivudine in NNRTI-based antiretroviral regimens: a prospective study.在基于非核苷类逆转录酶抑制剂的抗逆转录病毒治疗方案中,长期使用司他夫定/拉米夫定后换用替诺福韦/拉米夫定的代谢益处:一项前瞻性研究。
J Infect. 2011 May;62(5):406-9. doi: 10.1016/j.jinf.2011.02.012. Epub 2011 Mar 5.

引用本文的文献

1
A framework for sustainable capacity-building for collaborative North-South translational health research and training in a resource-constrained setting.资源有限环境下,促进可持续的合作式南北转化卫生研究与培训的能力建设框架。
Health Res Policy Syst. 2023 Mar 27;21(1):24. doi: 10.1186/s12961-023-00972-0.